Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

21.31
-1.4300-6.29%
Post-market: 21.320.0100+0.05%16:20 EDT
Volume:1.28M
Turnover:27.10M
Market Cap:1.36B
PE:-7.75
High:22.18
Open:22.18
Low:20.27
Close:22.74
Loading ...

Vera Therapeutics FY EPS USD -2.75 VS. Ibes Estimate USD -2.84

THOMSON REUTERS
·
26 Feb

Press Release: Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
26 Feb

Vera Therapeutics selloff a buying opportunity, says Evercore ISI

TIPRANKS
·
19 Feb

Buy Rating for Vera Therapeutics: Atacicept’s Unique Potential in the IgAN Market

TIPRANKS
·
19 Feb

Vera Therapeutics selloff Friday overblown, says JPMorgan

TIPRANKS
·
18 Feb

TD Cowen Remains a Buy on Vera Therapeutics (VERA)

TIPRANKS
·
18 Feb

Buy Rating Affirmed for Vera Therapeutics Amid Promising Atacicept Prospects and Market Overreaction Concerns

TIPRANKS
·
18 Feb

Vera reaction to competitor IgAN update ‘overdone,’ says Goldman Sachs

TIPRANKS
·
15 Feb

Vera Therapeutics weakness on Otsuka plans ‘makes no sense,’ says Wells Fargo

TIPRANKS
·
15 Feb

BRIEF-Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
14 Feb

Vera Therapeutics Initiated at Outperform by Wolfe Research

Dow Jones
·
04 Feb

Vera Therapeutics initiated with an Outperform at Wolfe Research

TIPRANKS
·
04 Feb

Goldman Sachs Initiates Vera Therapeutics at Buy With $58 Price Target

MT Newswires Live
·
28 Jan

Vera Therapeutics initiated with a Buy at Goldman Sachs

TIPRANKS
·
28 Jan

Vera Therapeutics: Promising Clinical Progress and Strategic Positioning Drive Buy Rating

TIPRANKS
·
23 Jan

TD Cowen Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
21 Jan

Possible Bearish Signals With Vera Therapeutics Insiders Disposing Stock

Simply Wall St.
·
20 Jan

Vera Therapeutics: Strategic Licensing and Promising Clinical Data Justify Buy Rating

TIPRANKS
·
15 Jan

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
15 Jan

Vera Therapeutics Acquires Global Rights to Dual BAFF/APRIL Inhibitor

MT Newswires Live
·
14 Jan